Esperion Therapeutics
ESPR
ESPR
157 hedge funds and large institutions have $803M invested in Esperion Therapeutics in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 52 increasing their positions, 52 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
31% less capital invested
Capital invested by funds: $1.17B → $803M (-$364M)
35% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 26
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
157
Holding in Top 10
1
Calls
$11.6M
Puts
$15.1M
Top Buyers
| 1 | +$41.3M | |
| 2 | +$18.7M | |
| 3 | +$18.1M | |
| 4 |
Morgan Stanley
New York
|
+$5.22M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.42M |
Top Sellers
| 1 | -$43.5M | |
| 2 | -$23.7M | |
| 3 | -$14.6M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
-$12.3M |
| 5 |
AG
Artal Group
Luxembourg
|
-$9.29M |